Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Burce Goktaş"'
Autor:
İrfan Cicin, Mohammed Oukkal, Hassen Mahfouf, Amel Mezlini, Blaha Larbaoui, Slim Ben Ahmed, Hassan Errihani, Khalid Alsaleh, Rhizlane Belbaraka, Perran Fulden Yumuk, Burce Goktas, Mustafa Özgüroğlu
Publikováno v:
European Journal of Breast Health, Vol 18, Iss 1, Pp 63-73 (2022)
Objective:This study was designed to investigate treatment satisfaction in patients and Health Care Professionals (HCP) and to evaluate the safety and tolerability of subcutaneous (SC) trastuzumab in patients with human epidermal growth factor recept
Externí odkaz:
https://doaj.org/article/44aa8ae6d88d49109eadb32a73987363
Autor:
Tülay Canda, Ekrem Yavuz, Necmettin Özdemir, Sennur İlvan, Serpil Sak Dizbay, Merih Güray Durak, Sıtkı Tuzlalı, Osman Zekioğlu, Atakan Demir, Handan Onur, Kasım Üstündağ, Burçe Göktaş
Publikováno v:
European Journal of Breast Health, Vol 14, Iss 3, Pp 160-165 (2018)
Objective: As patients with increased human epidermal growth factor receptor (HER2) overexpression are more likely to benefit from trastuzumab treatment, the accuracy of HER2 receptor status in breast cancer patients is significant for appropriate di
Externí odkaz:
https://doaj.org/article/0ce1214ddc9f43f8aa5dbf4aada0330f
Autor:
Huseyin Abali, Suayib Yalcin, Huseyin Cem Onal, Faysal Dane, Berna Oksuzoglu, Nuriye Ozdemir, Huseyin Mertsoylu, Mehmet Artac, Celaletdin Camci, Bulent Karabulut, Fatma Bugdayci Basal, Burcin Budakoglu, Mehmet Ali Sendur, Burce Goktaş, Fatih Ozdener, Arzu Baygul
BackgroundTrastuzumab prolonged the overall survival in patients with advanced gastric cancer with HER2 overexpression in combination with chemotherapy. In this phase II open-label prospective study, the tolerability and safety of trastuzumab with ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::772b26d2566cffb1f38961b4262fb643
https://doi.org/10.21203/rs.3.rs-16111/v1
https://doi.org/10.21203/rs.3.rs-16111/v1
